Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

Medicine, Oncology, Radiation Oncology +12

Genetic Pathways to Glioblastoma

Hiroko Ohgaki, Pierre Dessen, Benjamin Jourde et al. · Cancer Research · 2004 · 1.3K citations · Full text

Medicine, Genetics, Oncology +15

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

Shiqing Li, Karl R. Schmitz, Philip D. Jeffrey et al. · Cancer Cell · 2005 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +13

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

Alberto Sobrero, Joan Maurel, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2008 · 952 citations · Full text

Medicine, Oncology, Pharmacology +14

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

Neil I. Goldstein, Marie Prewett, Kazys Zuklys et al. · PubMed · 1995 · 790 citations

Medicine, Oncology, Pharmacology +14